home.social

#pharmaceuticalcompany — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #pharmaceuticalcompany, aggregated by home.social.

fetched live
  1. europesays.com/dk/171897/ Novo’s CEO Called Ozempic’s Patent Cliff the “Elephant in the Room” Yesterday. Is the Stock Still a Buy? #MikeDoustdar #NovoNordisk #PharmaceuticalCompany

  2. Vaccine production site in Germany’s Dresden to close after 115 years

    The GlaxoSmithKline (GSK) logo can be seen in front of the Dresden serum plant. According to the union,…
    #Germany #DE #Europe #EU #Europa #Dresden #fluvaccines #GlaxoSmithKline #pharmaceuticalcompany #Production #Vaccineproduction
    europesays.com/germany/88955/

  3. SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination

    SciSparc Ltd TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”),…
    #EuropeSays #Japan #JP #Japanese #Japanesepatent #Japanesepatentcoverage #JapanesePatentOffice #NeuroTheraLabsInc. #pharmaceuticalcompany #pharmaceuticaldevelopments #proprietarycombination #SciSparcLtd #theCompany
    europesays.com/japan/73147/

  4. AstraZeneca Shares Drop on Report of Potential Merger Talks with Bristol Myers Squibb

    Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca PLC (LSE:AZN) shares fell almost 7% in London trading…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #Bristol-MyersSquibbCompany #earningspershare #pharmaceuticalcompany
    europesays.com/britain/97084/

  5. Is Bristol Myers Squibb’s Dividend Too Good to Be True? Here’s My Honest Answer

    When dividend yields start to creep up, it’s worth taking a closer look for any potential warning signs.…
    #Bristol #UnitedKingdom #UK #GB #England #Headlines #News #Europe #EU #Bristol-MyersSquibb #Britain #dividendyields #Freecashflow #GreatBritain #pharmaceuticalcompany
    europesays.com/uk/1113786/

  6. Lilly to file for next-gen obesity drug approval in early 2027

    Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
    #NewsBeep #News #Medication #approval #bloodsugarlevels #EliLilly #Health #NovoNordisk #Obesity #pharmaceuticalcompany #treatmentforobesity #UK #UnitedKingdom
    newsbeep.com/uk/710710/

  7. Lilly to file for next-gen obesity drug approval in early 2027

    Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
    #NewsBeep #News #Medication #approval #AU #Australia #bloodsugarlevels #EliLilly #Health #NovoNordisk #Obesity #pharmaceuticalcompany #treatmentforobesity
    newsbeep.com/au/821404/

  8. From where I stand, the linked article below looks like an opportunistic partisan move. In my view, people from both sides of the dispute (#MAPS AND #Psymposia) managed to slow down the progress of #psychedelicMedicine (maybe for good).
    But I agree with Ms. Devenot that, specially by tagging #Left on the title, it is a "transparently partisan attack" that "politicized whistleblowers to appeal to the #Trump administration on behalf of a #pharmaceuticalcompany." (#Lykos)

    nytimes.com/2025/02/04/health/

  9. Dementia affects 55 million people worldwide, and its most common form, Alzheimer's, accounts for about 70 percent of all cases.At the Alzheimer's Associatio...
    Edo Richard and Craig Ritchie: Are Alzheimer's drugs false hope? | Talk to Al Jazeera
Share on Mastodon

Enter the server where you have an account.